• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

3B Scientific to acquire Cardionics

Share:

July 22, 2019

3B Scientific, a portfolio company of JH Whitney Capital Partners and a leading manufacturer and marketer of anatomical and biological education and simulation products for science, healthcare and patient education announced the acquisition of Excellus Technologies, Inc. dba Cardionics, a leader in Auscultation Simulation products.

“Cardionics is a perfect addition to 3B Scientific’s line of Medical Education and Simulation Products,” said Todd Murray, CEO of 3B Scientific. “We continue to develop deep and broad penetration into the global medical simulation market and Cardionics auscultation products provide strong synergies and an excellent focused offering to complement the overall 3B Scientific simulation line.”

Cardionics Chief Operating Officer Andy Strandell will continue in his role with Cardionics and is excited about the future growth prospects of the two companies. “The combination of 3B Scientific and Cardionics is an ideal combination to take advantage of the global distribution capabilities of 3B Scientific with the category leading auscultation products of Cardionics. I look forward to working closely with the new team.”

The healthcare simulation market has experienced significant growth in the past decade and is estimated to reach USD $2.27 Billion by 2021, according to a 2016 Markets and Markets report.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: July 22, 2019

Source: 3B Scientific

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • In-App Chat: the Future of Secure Doctor/Patient Communications?In-App Chat: the Future of Secure Doctor/Patient Communications?
  • Foamix Pharm And Menlo Therapeutics To Merge – Quick FactsFoamix Pharm And Menlo Therapeutics To Merge – Quick Facts
  • Quest Diagnostics and Newyork-presbyterian Complete Laboratory Services AcquisitionQuest Diagnostics and Newyork-presbyterian Complete Laboratory Services Acquisition
  • Cigna International Taps Teladoc Health to Expand Telehealth Capabilities in IndiaCigna International Taps Teladoc Health to Expand Telehealth Capabilities in India
  • Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth PlatformLemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform
  • Remedy Health Media Acquires OBR OncologyRemedy Health Media Acquires OBR Oncology
  • Healx Raises $56M Series B to Use AI to Find Treatments for Rare DiseasesHealx Raises $56M Series B to Use AI to Find Treatments for Rare Diseases
  • Revelation Pharma Completes Two AcquisitionsRevelation Pharma Completes Two Acquisitions

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications